Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Rat CDK9 Protein

Cat.No. : CDK9-1309R
Product Overview : Recombinant Rat CDK9 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Rat
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 EU per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
Storage Buffer : PBS buffer
Gene Name : Cdk9 cyclin-dependent kinase 9 [ Rattus norvegicus ]
Official Symbol : CDK9
Gene ID : 362110
mRNA Refseq : NM_001007743.1
Protein Refseq : NP_001007744.1
MIM :
UniProt ID : Q641Z4

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (5)

Ask a question
Is CDK9 targeted only for cancer and antiviral therapies, or are there other applications? 12/04/2021

Besides cancer and antiviral therapies, CDK9 is being explored for its role in other diseases, including neurodegenerative disorders.

Can CDK9 inhibitors be used in combination with other cancer treatments? 05/04/2021

Yes, combination therapies involving CDK9 inhibitors and other drugs are being investigated to enhance treatment outcomes.

How does the expression of CDK9 vary in different stages of cancer progression? 07/03/2020

CDK9 expression tends to increase as cancer progresses, suggesting its potential as a biomarker for disease severity.

How does CDK9 inhibition affect normal cellular functions? 12/22/2019

CDK9 inhibitors can impact normal cell functions, leading to potential side effects such as myelosuppression.

Are there ongoing clinical trials involving CDK9 inhibitors? 07/08/2017

Yes, several clinical trials are exploring the effectiveness of CDK9 inhibitors in different cancer types.

Customer Reviews (3)

Write a review
Reviews
08/31/2020

    Its remarkable quality, versatility, and the manufacturer's commitment to customer satisfaction make it the perfect choice for researchers seeking a premier protein that will undoubtedly enhance their experimental endeavors.

    06/26/2019

      In addition to its remarkable quality and exceptional technical support, the CDK9 Protein boasts an impressive range of applications.

      09/12/2018

        The CDK9 Protein has exceeded my expectations by consistently delivering outstanding results and providing exceptional technical support.

        Ask a Question for All CDK9 Products

        Required fields are marked with *

        My Review for All CDK9 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends